Accurately measure pharmacodynamic protein biomarkers to support decisions in clinical trials.

Data generated in our CLIA certified laboratory can:

  • Identify and validate biomarkers
  • Monitor drug effects on key pathways
  • Guide dose selection
  • Aid in measuring efficacy

Testing services are facilitated by a project management team experienced in supporting clinical trials and drug development programs. Rules-Based Medicine (RBM) a Q2 Solutions Company’s Multi-Analyte Profile (MAP) and Simoa platforms provide investigators with reliable results that allow discovery, validation, and clinical use of pharmacodynamic biomarkers in a cost-effective, efficient manner.

RBM provides industry-leading protein biomarker products and services based on our Multi-Analyte Profile (MAP) platform.
Use our products and services to advance your research, drug and diagnostic development projects.

See how other investigators have applied our services for drug development.

Learn about our assay validation from the QC white paper: An Overview of Assay Quality Systems at Rules-Based Medicine a Q2 Solutions Company 

Read the Quality Control White Paper